Chinese biotech startup I-Mab raises $220m Series C led by Hony Capital

Chinese biotech startup I-Mab raises $220m Series C led by Hony Capital

Photo: Bloomberg

Chinese biotechnology startup I-Mab Biopharma has raised $220 million in a Series C round led by Hony Capital and joined by Hillhouse Capital, HOPU Investments, CDH Investment, Ally Bridge Group, Singapore-based EDBI, as well as existing investors C-Bridge Capital and Tasly Capital.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter